CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner

作者
Songping Xie,Zhenbo Tu,Jie Xiong,Ganjun Kang,Lina Zhao,Weidong Hu,Haiyan Tan,Kingsley Miyanda Tembo,Qianshan Ding,Xinzhou Deng,Jie Huang,Qiuping Zhang
出处
期刊:Oncology Reports [Elsevier BV]
卷期号:37 (2): 921-928 被引量:35
标识
DOI:10.3892/or.2016.5289
摘要

Chemoresistance is the main cause of treatment failure and high mortality in advanced lung cancer. Cisplatin, an important chemotherapeutic agent for lung cancer, has been observed to show enormously reduced chemotherapeutic efficacy owing to the development of chemoresistance. CXCR4, a stromal-derived-factor-1 specific chemokine receptor, is highly expressed in non-small cell lung cancer (NSCLC) tissues and participates in cancer progression by regulating cell growth, apoptosis or invasion. In this study, we therefore investigated whether CXCR4 plays a role in the cisplatin associated resistance in NSCLC. We detected the expression of CXCR4 in tissue specimens from 64 NSCLC patients by immunohistochemistry. Cisplatin-resistant NSCLC cells A549/DDP and its parental A549 cells were employed in this study. RNA interference was performed to silence the CXCR4. The influence of CXCR4 on tumor cell chemoresistance, apoptosis and growth, as well as the relationship between CXCR4 and the expression of cytochrome p450 associated molecule CYP1B1 in NSCLC were evaluated. Finally, we found CXCR4 was significantly highly expressed in cisplatin-resistant NSCLC patients and the A549/DDP cell line. CXCR4 inhibition by siRNA reversed chemoresistance and decreased tumor cell proliferation. Bioinformatics analysis showed that the expression of CYP1B1 had a positive correlation with CXCR4, the CYP1B1 silencing significantly decreased CXCR4 expression levels and cisplatin resistance. Immunohistochemistry also verified that CYP1B1 was upregulated in NSCLC tissues of cisplatin-resistant patients. In conclusion, our results indicate that overexpression of CXCR4 in NSCLC promotes cisplatin resistance via CXCR4-mediated CYP1B1 upregulation. Thus, it can be used as a potential therapeutic target in NSCLC chemoresistance patients and be used as a clinical predictor of cisplatin response.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
共享精神的应助被牧百川采纳,获得10
3秒前
彭于晏的应助被277采纳,获得10
3秒前
3秒前
4秒前
欣慰忆山完成签到,获得积分10
4秒前
情怀的应助被Hyphen采纳,获得10
5秒前
5秒前
英姑的应助被王震采纳,获得10
6秒前
7秒前
端庄书雁发布了新的文献求助10
7秒前
刘辉发布了新的文献求助10
7秒前
tingt完成签到,获得积分10
9秒前
夏夏夏发布了新的文献求助10
9秒前
dianhuaxue发布了新的文献求助10
9秒前
9秒前
10秒前
Ian发布了新的文献求助10
10秒前
Akim的应助被fx采纳,获得10
10秒前
风趣乐天发布了新的文献求助10
10秒前
10秒前
Lisa的应助被fx采纳,获得10
10秒前
zkylh的应助被fx采纳,获得10
10秒前
Lucas的应助被fx采纳,获得10
11秒前
香蕉觅云的应助被zzk采纳,获得10
11秒前
fwfl250发布了新的文献求助10
11秒前
蜡笔小新完成签到 ,获得积分10
12秒前
猴子的应助被明亮白山采纳,获得10
12秒前
12秒前
领导范儿的应助被傻傻的灵寒采纳,获得10
13秒前
13秒前
13秒前
13秒前
HHW发布了新的文献求助10
14秒前
wanci的应助被牧百川采纳,获得10
14秒前
良行知发布了新的文献求助10
14秒前
14秒前
英姑的应助被jackson_WANG采纳,获得10
15秒前
tldsnhzrs完成签到,获得积分10
15秒前
小梅同学完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183298
求助须知:如何正确求助?哪些是违规求助? 9572606
关于积分的说明 21826444
捐赠科研通 7780272
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558136
邀请新用户注册赠送积分活动 2480259